发明名称 |
NON-PEPTIDE INHIBITION OF T-LYMPHOCYTE ACTIVATION AND THERAPIES RELATED THERETO |
摘要 |
Compounds, preparations and methods for immunosuppressive treatment of autoimmune disorders, graft rejection and/or graft/host disease. Therapeutically effective amounts of certain substituted triarylmethane compounds, such as 1-[(2-chlorophenyl)diphenylmethyl]-1<i>H</i>-pyrazole, are administered to mammalian patients to selectively inhibit the calcium-activated K<+> channel (<i>IKCa1</i>) in Lymphocytes, monocytes, macrophages, platelets or endothelial cells without concomitant inhibition of P450-dependent enzyme systems, resulting in reduction of antigen-,cytokine-, or mitogen-induced calcium entry through store operated calcium channels in these cells, suppression of cytokine production by these cells, and inhibition of activation of these cells. Such inhibition of the Ca<++> activated K<+> channel (<i>IKCa1</i>) prevents the pre-Ca<++> stage of cell activation and thus causes immunosuppression and an anti-inflammatory response.
|
申请公布号 |
WO0149663(A3) |
申请公布日期 |
2002.02.07 |
申请号 |
WO2001US00326 |
申请日期 |
2001.01.05 |
申请人 |
|
发明人 |
CHANDY, K., GEORGE;WULFF, HEIKE;CAHALAN, MICHAEL, D.;GRISMER, STEPHAN;RAUER, HEIKO, J.;MILLER, MARK, J. |
分类号 |
A61K31/16;A61K31/277;A61K31/40;A61K31/41;A61K31/415;A61K31/425;(IPC1-7):A61K31/415 |
主分类号 |
A61K31/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|